Singapore's sovereign wealth fund, GIC Private Limited, has decreased its investment in Rentokil Initial plc, a global pest-control and hygiene services provider. A regulatory filing on March 4 revealed the fund's stake was lowered to 3.25%, representing 82.2 million voting rights, down from a previous holding of 3.99%. This move comes shortly after Rentokil disclosed its full-year 2025 financial performance and amid an ongoing executive leadership handover.
Financial Performance and Market Expectations
Rentokil reported its 2025 results on March 5, revealing group revenue of $6.91 billion, an increase from the prior year. Adjusted operating profit reached $1.07 billion, while underlying sales growth, measured as organic growth, was 2.6% for the year. Despite weather-related disruptions in North America during January and broader geopolitical uncertainties, the company stated it anticipates its 2026 performance will align with current market expectations.
Investors responded positively to the report, driving the company's share price up by 10.7% on the day of the announcement. This gain occurred even as the broader FTSE 100 index declined by 1.5%.
North American Operations Under Scrutiny
A significant focus for the market remains Rentokil's performance in North America, its largest regional market. The company has faced challenges in the region, including a complex integration following its acquisition of U.S. rival Terminix. In its results, Rentokil noted encouraging progress, with pest-control organic growth in North America improving to 2.6% in the fourth quarter, a substantial recovery from 0.1% in the first half of the year.
Executive leadership highlighted strategic efforts, including a push on local branding, branch network expansion, and more targeted marketing, which contributed to a 7.1% growth in residential lead flow during the second half. Outgoing CEO Andy Ransom described 2025 as a year of "encouraging progress," outlining plans to maintain approximately 30 brands in the region and expand the branch network to around 800 locations by the end of 2026.
Management Transition and Ongoing Risks
The change in shareholding coincides with a scheduled management transition. Mike Duffy, who was appointed in January and joined as CEO-designate in February, is set to officially assume the role of chief executive on March 16. Concurrently, Chairman Richard Solomons plans to retire once a successor is appointed.
Despite improved metrics, risks persist. The company recorded a significant $201 million charge in 2025 related to termite damage claims, with $122 million of that added in the second half alone. The total year-end provision for expected claims stands at $384 million. Management indicated that the cash outflow for these claims in 2026 is likely to be similar to the 2025 level.
Competitive Landscape and Future Outlook
The competitive environment in the U.S. pest-control market remains intense. Rentokil and its main competitor, Rollins, are estimated to control roughly half of the market collectively. Notably, Rollins reported weaker-than-expected quarterly revenue and earnings in February, citing softer demand, which underscores the competitive pressures in the sector.
Rentokil's next scheduled communication with the market is a first-quarter trading statement, due on April 16. Investors and analysts will be watching closely for further signs of stabilization in North America and early indications of the new CEO's strategic direction.
